Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Takehiro Funamizu, M.D., Ph.D.

Concepts (83)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Psoas Muscles12021660.710 Why?
Coronary Artery Disease7202465440.400 Why?
Diabetes Mellitus4202458890.350 Why?
Hypoglycemic Agents1202031060.280 Why?
Blood Glucose1202064220.240 Why?
Chemokine CXCL12120244550.190 Why?
Japan2202014110.150 Why?
Intra-Aortic Balloon Pumping120202220.150 Why?
Cholesterol, HDL2202218130.150 Why?
Dipeptidyl-Peptidase IV Inhibitors120223170.140 Why?
Cardiovascular Diseases22022156450.140 Why?
Chemotaxis120205960.140 Why?
Heart Failure12021118370.130 Why?
Kaplan-Meier Estimate3202165030.120 Why?
Lipoprotein(a)120204880.120 Why?
Nutrition Assessment120187380.120 Why?
Cause of Death3202037150.120 Why?
Device Removal120206430.120 Why?
Secondary Prevention1202014700.110 Why?
Continuous Positive Airway Pressure120185810.110 Why?
Drug-Eluting Stents120196800.110 Why?
Atrial Fibrillation2202151860.100 Why?
Malnutrition120186290.100 Why?
Retrospective Studies102024815370.090 Why?
Monocytes1202025910.090 Why?
Geriatric Assessment1201814220.090 Why?
Sleep Apnea Syndromes120189820.090 Why?
Prognosis52021298900.080 Why?
Myocardial Ischemia1201921320.080 Why?
Extracorporeal Membrane Oxygenation1202014810.080 Why?
Treatment Outcome82024651940.080 Why?
Aged1020211711630.070 Why?
Plaque, Atherosclerotic1201815290.070 Why?
C-Reactive Protein1201838510.070 Why?
Postoperative Complications22019158020.070 Why?
Risk Factors72024748500.070 Why?
Proportional Hazards Models12021125290.070 Why?
Electrocardiography1201964090.060 Why?
Muscle, Skeletal1202149590.060 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1202032490.060 Why?
Databases, Factual1202080600.060 Why?
Time Factors32020400970.050 Why?
Registries1202083460.050 Why?
Body Mass Index12021130420.050 Why?
Cross-Sectional Studies22021262820.050 Why?
Male1120213638150.050 Why?
Risk Assessment22024242750.050 Why?
Dipeptidyl Peptidase 412022930.050 Why?
Female1120213961410.050 Why?
Aged, 80 and over32021594960.050 Why?
Middle Aged920212230160.050 Why?
Apolipoprotein A-I120223050.040 Why?
Insulin-Like Growth Factor Binding Protein 3120224160.040 Why?
Protein Isoforms1202417160.040 Why?
Humans1420247659260.040 Why?
Tokyo12018220.040 Why?
Stromal Cells1202413320.040 Why?
Follow-Up Studies42022392280.040 Why?
Diabetes Mellitus, Type 212022122350.040 Why?
Lung Neoplasms12022134460.040 Why?
Platelet Count120207840.030 Why?
Cyclic AMP1202114660.030 Why?
Lipoproteins, HDL120216760.030 Why?
Heart Atria1202113630.030 Why?
Survival Rate22019128220.030 Why?
Insulin-Like Growth Factor I1202219360.030 Why?
Cholesterol1202129020.020 Why?
Tachycardia, Ventricular1202013130.020 Why?
Incidence22019215130.020 Why?
Flow Cytometry1202058800.020 Why?
Neoplasms12018223400.020 Why?
Coronary Angiography1201944980.020 Why?
Survival Analysis12020100860.020 Why?
Catheter Ablation1202027870.020 Why?
Intensive Care Units1202037990.020 Why?
Thrombosis1201929550.020 Why?
Disease Progression12020136140.010 Why?
Case-Control Studies12020222280.010 Why?
Predictive Value of Tests12018154010.010 Why?
Randomized Controlled Trials as Topic12018103800.010 Why?
Myocardial Infarction12019115080.010 Why?
Stroke1201997390.010 Why?
Prospective Studies12018548070.010 Why?
Funamizu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (83)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.